TickerFacts.

AIM ImmunoTech Inc. (AIM): Cost of Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cost of Revenue is for the year ended 2014-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$1.25M
Year ended 2014-12-31
+6.2%
3-year compound annual growth
+16.5%
5-year compound annual growth
$1.99M2009-12-31: $584.0K2010-12-31: $1.34M2011-12-31: $1.04M2012-12-31: $1.99M2013-12-31: $1.23M2014-12-31: $1.25M$1.25M
2009-12-31 Cost of Revenue (USD) 2014-12-31
Period endedCost of RevenueChange YoYSource filing
2014-12-31$1.25M+1.4%2015-03-19, From 2014-01-01
2013-12-31$1.23M-38.0%2015-03-19, From 2013-01-01
2012-12-31$1.99M+90.7%2015-03-19, From 2012-01-01
2011-12-31$1.04M-22.2%2014-03-14, From 2011-01-01
2010-12-31$1.34M+129.6%2013-03-18, From 2010-01-01
2009-12-31$584.0Kn/a2012-03-14, From 2009-01-01